# OR51V1

## Overview
The OR51V1 gene encodes the protein olfactory receptor family 51 subfamily V member 1, which is part of the G-protein-coupled receptor (GPCR) superfamily. These receptors are primarily involved in the detection of odorants, playing a crucial role in the olfactory system by initiating neuronal responses that lead to the perception of smell. The OR51V1 protein is characterized by its seven-transmembrane domain structure, typical of GPCRs, which allows it to traverse the cell membrane and interact with specific ligands. While the primary function of OR51V1 is related to olfaction, recent studies have suggested potential roles in other physiological processes, including genetic associations with thromboembolic events in sickle cell disease (Alshabeeb2023Impact). Further research is needed to fully elucidate the diverse functions and clinical implications of this olfactory receptor.

## Clinical Significance
The clinical significance of the OR51V1 gene, part of the olfactory receptor family, is primarily explored in the context of genetic variations associated with thromboembolic events (TEEs) in individuals with sickle cell disease (SCD). A missense mutation, rs7933549, in OR51V1 has been significantly associated with increased risk of TEEs and stroke in Saudi patients with SCD, suggesting a potential role in modifying thromboembolic risk (Alshabeeb2023Impact). 

Research also indicates that mutations in olfactory receptor genes, including OR51V1, may influence chromatin structure and gene-receptor interactions, potentially affecting the expression of genes like HBG, which could have implications for hemolysis and fetal hemoglobin (HbF) levels (Alshabeeb2023Impact). However, the specific clinical significance of OR51V1 mutations in diseases beyond these associations is not well-documented.

In the context of synthetic genome-wide associations, OR51V1 is located near significant association signals for sickle cell anemia, suggesting that rare variants in this region might contribute to synthetic associations with common variants, potentially affecting disease understanding and treatment strategies (Dickson2010Rare). Despite these findings, the direct clinical implications of OR51V1 mutations remain under investigation.


## References


[1. (Alshabeeb2023Impact) Mohammad A. Alshabeeb, Deemah Alwadaani, Farjah H. Al Qahtani, Salah Abohelaika, Mohsen Alzahrani, Abdullah Al Zayed, Hussain H. Al Saeed, Hala Al Ajmi, Barrak Alsomaie, Mamoon Rashid, and Ann K. Daly. Impact of genetic variations on thromboembolic risk in saudis with sickle cell disease. Genes, 14(10):1919, October 2023. URL: http://dx.doi.org/10.3390/genes14101919, doi:10.3390/genes14101919. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes14101919)

[2. (Dickson2010Rare) Samuel P. Dickson, Kai Wang, Ian Krantz, Hakon Hakonarson, and David B. Goldstein. Rare variants create synthetic genome-wide associations. PLoS Biology, 8(1):e1000294, January 2010. URL: http://dx.doi.org/10.1371/journal.pbio.1000294, doi:10.1371/journal.pbio.1000294. This article has 694 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1371/journal.pbio.1000294)